(Q35394210)

English

The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

The first FDA marketing authorizations of next-generation sequencing technology and tests: challenges, solutions and impact for future assays (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit